Every action the EHN undertakes aims to achieve its mission – to prevent and reduce CVD.
The EHN strives on a Strategic Plan, the current plan spans from 2019-2023. It’s really important to not forget about CVD, even though there has been a decline in CVD over the decades it still remains to be the leading cause of death in Europe. During the EHN’s 25 years of existence we have demonstrated that we are here to engage with policymakers and influence policies that ultimately contribute to promoting cardiovascular health and preventing CVDs.
The EHN’s Strategic Plan 2019-2023 encompasses three pillars (general objectives):
- Prevent avoidable CVD
- Strengthen the support for people with CVD
- Reinforce CVD research
The three pillars are supported by horizontal objectives.
The horizontal objectives aim to further our advocacy, networking and capacity building work as well as enhancing organisational strengths by building our memberships across Europe, strengthening cooperation’s with our partners and continuing to work in alliances.
The EHN is known for its contributions to politics, policy and research. We release a number of publications because we are passionate about the union between ‘science’ and ‘health policy’ in order to achieve our goals within the cardiovascular field and increase innovation in treatment and prevention.
Across Europe, the EHN has 27-member organisations and they are composed of either:
Heart Foundations – Charities that aim to finance CVD research at national levels.
Patient Associations – Groups that aim to inform patients on how to manage CVD and unite CVD patients.
The EHN fosters this wonderful network so that there can be sharing of information surrounding the topic of CVD across Europe.